Detalhe da pesquisa
1.
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors.
Cancer
; 125(16): 2837-2845, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012962
2.
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer.
Cancer Res Commun
; 3(8): 1672-1677, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645623
3.
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.
Cancer Res Commun
; 3(2): 338-346, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36860652
4.
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.
bioRxiv
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904980
5.
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence.
Clin Epigenetics
; 14(1): 166, 2022 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463226
6.
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy.
Cancer Cell
; 40(11): 1374-1391.e7, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306792
7.
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity.
Cancer Cell
; 39(7): 973-988.e9, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115989
8.
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma.
Clin Cancer Res
; 27(5): 1278-1286, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277370
9.
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma.
Oncotarget
; 11(21): 1929-1941, 2020 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32523648
10.
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer.
Clin Cancer Res
; 26(19): 5129-5139, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591464
11.
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer.
Clin Cancer Res
; 26(14): 3578-3588, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273276
12.
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer.
Cancer Med
; 9(4): 1485-1494, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876399
13.
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer.
Clin Cancer Res
; 26(13): 3182-3192, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173650
14.
Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade.
J Clin Oncol
; 37(36): 3546-3555, 2019 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675272
15.
Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade.
Clin Cancer Res
; 25(23): 7024-7034, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31506389
16.
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy.
Cancer Immunol Res
; 7(10): 1574-1579, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439614
17.
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.
Science
; 364(6439): 485-491, 2019 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048490
18.
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors.
Clin Cancer Res
; 25(17): 5250-5259, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061070
19.
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
J Immunother Cancer
; 7(1): 63, 2019 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30841906
20.
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
J Immunother Cancer
; 7(1): 40, 2019 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30744692